After further thought I would be happy with LTI of vesting for T3 occurring either of
50% of nameplate production of saleable product (20k oz p.a. gold, 2,700 kt p.a. Antimony run rate for 2 consecutive quarters); or
First production and shipment of a commercial level of saleable antimony concentrate [~55.6%] prior to H2 CY2026 (30 June 2026 cut off for first shipment to vest)
because the goal is to align long term growth of the company, not the share price pumping for two weeks to a level shareholders have already seen.
I don't think there is a shareholder here who wouldn't want management to be incentivized to bring this into commercial production - even the funds - I am looking at you 1832 and Gage
LRV Price at posting:
82.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)